Home SurGenTec Submits IPO Filing Following FDA Approval of OsteoFlo HydroFiber Synthetic Bone Graft for Spinal Surgery

SurGenTec Submits IPO Filing Following FDA Approval of OsteoFlo HydroFiber Synthetic Bone Graft for Spinal Surgery

Feb 05, 2025 16:02 CST Updated 16:02
SurGenTec

Medical Device Developer